A team led by David Kostin made at least their third upgrade to S&P 500 forecasts this year. They now expect the S&P 500 SPX to reach 6,000 in three months' time, versus 5,600 previously, and 6,300 in ...

Bristol Myers Squibb's schizophrenia drug, which received FDA approval last week, took a long and winding road to get there. Three decades ago, Eli Lilly developed the drug's forerunner, xanomeline, ...

A stronger than expected jobs report on Friday further eased fears of a slowing economy and allowed markets to stage ...

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance.

Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...

Hong Kong shares jumped again, rising 1.60% the day before mainland China markets reopen. Beijing said it would explain the ...

Elon Musk appeared onstage at a rally for the former president this weekend, but Silicon Valley was abuzz about Ben ...

Activist investor Starboard Value has set its sights on Pfizer.

Dow, S&P 500, and Nasdaq futures are falling in premarket trading Monday as the stock market weighs up Middle East fears and looks ahead to CPI inflation data.

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Starboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the ...